drugset / Trial / NCT01167049
Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To investigate the efficacy of capecitabine combined with paclitaxel as neoadjuvant chemotherapy for gastric cancer with liver metastasis only
Timeline
- Start
- 2009-08
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 1000 mg/m2 | Oral |
| Subject | Paclitaxel | Small molecule | 80 mg/m2 | Intravenous |